lysine has been researched along with zalcitabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Caliendo, AM; D'Aquila, RT; DeVore, KM; Eron, JJ; Hirsch, MS; Kaplan, JC; Zhang, D | 1 |
| Bacheler, L; Koontz, D; Mellors, JW; Parikh, UM | 1 |
3 other study(ies) available for lysine and zalcitabine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase.
Topics: Arginine; Base Sequence; Cell-Free System; Codon; Deoxycytosine Nucleotides; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; HIV Reverse Transcriptase; Humans; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Recombinant Proteins; RNA-Directed DNA Polymerase; Zalcitabine | 1994 |
The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.
Topics: Adenine; Amino Acid Substitution; Anti-HIV Agents; Arginine; Didanosine; Dideoxynucleosides; Drug Resistance, Multiple, Viral; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lysine; Organophosphonates; Phenotype; Point Mutation; Reverse Transcriptase Inhibitors; Tenofovir; Thymidine; Zalcitabine; Zidovudine | 2006 |